The Fab'-fragment of a mouse IgA- 
An antibody-combining site is contained within an Fabfragment (1), which is composed of a light chain (L) and the N-terminal half (Fd) of a heavy chain (2) . It is generally agreed that antibody specificity results from different aminoacid sequences; this suggestion is strongly supported by experiments on refolding of completely unfolded Fab or peptide chains (3) (4) (5) (6) . However, only the N-terminal half of L-chain (105-109 residues) or of Fd (115-120 residues) contains sequences that vary from one immunoglobulin to another, whereas the C-terminal half of Fab has the same sequence for fragments derived from molecules of the same subclass. Theoretically, it is possible for a binding site in the constant region to be modulated by different sequences in the variable region. It is also possible that the constant region of the Fab is necessary for maintenance of the combining site.
Fab-fragment (molecular weight 50,000) can be obtained by various methods (7) . An early report (8) on the production of a smaller fragment (molecular weight about 13,000) by digestion of Fab with papain in 6 1\[ urea was not followed up, and other attempts to produce an active fragment with molecular weight smaller than 46,000 have failed (9) . We present direct evidence for the localization of the antibody combining site in the variable region of both H and L chains by obtaining a fragment, denoted Fv, that consists of the N-terminal half of the Fab, and retains the complete antibody-binding site. Our approach was based partly on the observation that under acidic conditions, light chain can be split with pepsin into variable and constant fragments (10 (13) .
Disc gel electrophoresis was performed in neutral sodium dodecyl sulfate on 10% polyacrylamide (14) . Protein markers were heavy and light chains of rabbit IgG, ovalbumin, trypsin, lysozyme, and cytochrome c. Gels were stained with Coomassie brilliant blue, and the RF of each band was plotted against the logarithm of the molecular weight.
Aminoacid analyses were performed on a Beckman 120B aminoacid analyzer. Protein samples were hydrolyzed in evacuated tubes with 6 N HCl at 110°for 24 hr. The value for half-cystine was obtained from aminoacid analysis of samples oxidized with performic acid. Tryptophan content was calculated from the absorbance of the protein in 6 M guanidine hydrochloride at 288 and 280 nm (15) . The sequence of N-terminal residues was determined (16) (20) .
To determine if the Fv-fragment contains the variable parts of Fab', we analyzed the N-terminal aminoacid sequence. The first eight residues were Asp-Val-Glx-Leu-GlxGlx-Ser-Gly. This is identical to that of the N-terminus of the heavy chain of protein-315 (S. Francis, R.G.Q. Leslie, L. Hood, and H. N. Eisen, personal communication). The fact that the molecular weight in sodium dodecyl sulfate is half of the molecular weight in aqueous buffer argues for the presence of two chains in Fv. However, the light chain has a blocked amino terminus [pyrollidone carboxyl residue (19)] and, therefore, only a single N-terminal sequence was obtained.
DISCUSSION
Our results show clearly that peptic cleavage of protein-315 yields a small fragment (Fv) that retains the binding activity of the original protein. This fragment is half the size of the Fab'-fragment, and its aminoacid composition and limited N-terminal aminoacid sequence are consistent with the view that it contains the N-terminal half of L chain and Fd, i.e., the variable segments designated VH and VL. The similar binding constant of Fv and Fab' indicates that the antibody site in this protein is contained entirely in the variable domains and is independent of the constant portion of the molecule. Fv contains 263 residues (Table 2) , about 33 residues more than expected for the sum of VH and VL. It is very likely, therefore, that each of the chains in Fv has 15-16 residues from the constant region. This is not surprising, since the C-terminal parts of VL and VH are in hypervariable regions that are involved in antibody-combining sites (21) and, therefore, must be left intact if antibody site is to be preserved. It seems likely that these additional 15 residues from the constant parts are in the interdomains area and, although t Determined by a spectroscopic method. not proven, we assume that they have no effect on the binding site. Currently, we are trying to digest Fv with carboxypeptidases to see how many of its C-terminal residues can be removed without diminution of its binding properties.
It has been demonstrated that in its reaction with Dnp ligands, protein-315 exhibits essentially all the characteristics of binding sites of conventionally prepared anti-Dnp antibodies (11) . Hence, it is likely that an active Fv-fragment may be obtainable from other antibodies, although the procedure may vary for antibodies from different species, and classes. Indeed, recent work on the light chains of rabbit antibodies to pneumococcal polysaccharides demonstrated that the N-terminal half of these light chains (VL) can be obtained by cleavage with dilute acid (22) . These cleaved chains, when recombined with homologous heavy chains, restored 78% of the original antibody activity.
Our results also suggest a modification of the "domain hypothesis" (23) , according to which each homologous region in an immunoglobulin chain (110-120 residues) folds separately as a globular domain, with less-tightly folded stretches of the peptide chain between domains. The present findings indicate that the VH and VL domains are intercalated and folded as a single globular unit, resistant to enzymic digestion. This is particularly consistent with recent x-ray analyses of human Fab' crystals (24) that clearly show the presence of two globular subunits (V and C) in Fab', each comprised of two domains, one of which probably corresponds to Fv (VL + VH) and the other to intercalated CL + CH1.
The availability of Fv-fragment may also permit the chemical synthesis of antibody-combining sites.
